InspireMD vs Picard Medical
NSPR and PMI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NSPR and PMI compare
InspireMD is the larger company, worth 1.8 times as much as Picard Medical ($29.9M against $16.9M).
InspireMD grew revenue faster over the last twelve months (53.4% versus 41.0% for Picard Medical).
Picard Medical keeps more of each dollar of sales as profit, with a net margin of −444% compared with −484% at InspireMD.
InspireMD scores higher on the StockData Score (10 against 7 for Picard Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NSPR | PMI |
|---|---|---|
| Size and price | ||
| Market cap | $29.9M | $16.9M |
| Share price | $0.644 | $7.23 |
| Change, 1 year | −64.0% | −94.7% |
| Change, 5 years | −82.7% | – |
| Beta (5Y) | 0.46 | −2.21 |
| Employees | 127 | 75 |
| StockData Score | ||
| Total score | 10 (better) | 7 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.8× | 2.7× (better) |
| P/B | 1.0× (better) | 9.9× |
| FCF yield | −142% | – |
| Fair value | $1.41 | $4.72 |
| Margin of safety | 54.4% (better) | −53.2% |
| Growth | ||
| Revenue growth (TTM) | 53.4% (better) | 41.0% |
| Revenue growth, 5Y average | 29.3% | – |
| Profitability | ||
| Gross margin | 18.1% | 18.6% (better) |
| Operating margin | −494% | −248% (better) |
| Net margin | −484% | −444% (better) |
| FCF margin | −392% | – |
| Return on equity | −203% | – |
| Return on invested capital | −4320% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 3.80 (better) | 1.02 |
| Altman Z-score | −11.98 (better) | −17.32 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | – | −81.2% |
| Shareholder yield | 0.00% (better) | −81.2% |
| Ownership | ||
| Held by institutions | 53.6% | 6.5% |
| Held by insiders | 31.6% | – |
| Insider net buying, 12 months | $369K | – |
| Short interest, % of float | 0.79% | – |
Go deeper
- NSPR stock overview
- NSPR income statement
- NSPR valuation and score
- PMI stock overview
- PMI income statement
- PMI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.